Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | HTR6 | P50406 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 6/20 | 0.40 |
| ▸ | HTR1A | P08908 | 2/20 | 0.40 |
| ▸ | HTR7 | P34969 | 2/20 | 0.40 |
| ▸ | DRD3 | P35462 | 2/20 | 0.40 |
| ▸ | HTR2B | P41595 | 2/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | PREP | P48147 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 2/20 | 0.32 |
| ▸ | HRH1 | P35367 | 2/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30901170 | 1.00 | ACHE (0.49) | ACHEHTR6HTR2AHTR1AHTR7 | |
| SCHEMBL30901165 | 1.00 | ACHE (0.49) | ACHEHTR6HTR2AHTR1AHTR7 | |
| Lithium SCHEMBL31213150 | 0.98 | ACHE (0.48) | ACHEHTR6HTR2AHTR1AHTR7 | |
| Hydrochloric Acid SCHEMBL30901171 | 0.97 | ACHE (0.47) | ACHEHTR6HTR2AHTR1AHTR7 | |
| Hydrochloric Acid SCHEMBL29262850 | 0.97 | ACHE (0.47) | ACHEHTR6HTR2AHTR1AHTR7 | |
| SCHEMBL29262847 | 0.94 | ACHE (0.45) | ACHEHTR6HTR2AHTR1AHTR7 | |
| SCHEMBL1453298 | 0.88 | HTR2A (0.42) | ACHEHTR6HTR2AHTR1AHTR7 | |
| SCHEMBL29262834 | 0.83 | HTR1A (0.39) | ACHEHTR6HTR2AHTR1AHTR7 | |
| SCHEMBL1453601 | 0.74 | HTR6 (0.40) | ACHEHTR6DRD2 | |
| SCHEMBL29262843 | 0.74 | ACHE (0.51) | ACHEHTR2AHTR1AHTR7DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118221849-A | Application of metallocene catalyst composition as catalyst in preparation of poly alpha olefin wax | 亚培烯科技(上海)有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-7910783-B2 | Preparation of substituted bridged indenyl and related ligands | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-03-22 | — | — | US | disclosed |
| EP-1971621-A1 | PREPARATION OF SUBSTITUTED BRIDGED INDENYL AND RELATED LIGANDS | ExxonMobil Chemical Patents Inc. (US) | 2008-09-24 | — | — | EP | disclosed |
| WO-2007070045-A1 | PREPARATION OF SUBSTITUTED BRIDGED INDENYL AND RELATED LIGANDS | EXXONMOBIL CHEMICAL PATENTS, INC. (US) | 2007-06-21 | — | — | WO | disclosed |
| US-20070135596-A1 | Preparation of substituted bridged indenyl and related ligands | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135596-A1 | Preparation of substituted bridged indenyl and related ligands | SP1, TTL, TTLL12 | ACHE 3416/4885HTR6 3192/4885HTR2A 4085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.